X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
index medicus (5) 5
adult (3) 3
aged (3) 3
disease-free survival (3) 3
middle aged (3) 3
antibodies, monoclonal - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
biology (2) 2
combined modality therapy (2) 2
drug administration schedule (2) 2
female (2) 2
follow-up studies (2) 2
hematology (2) 2
kaplan-meier estimate (2) 2
kinases (2) 2
lymphoma, large b-cell, diffuse - therapy (2) 2
lymphoma, non-hodgkin - mortality (2) 2
male (2) 2
non-hodgkins-lymphoma (2) 2
oncology (2) 2
proteins (2) 2
rituximab (2) 2
treatment outcome (2) 2
1st-line therapy (1) 1
aberrant expression (1) 1
abridged index medicus (1) 1
active transport, cell nucleus (1) 1
adolescent (1) 1
aged, 80 and over (1) 1
aggressive lymphoma (1) 1
analysis (1) 1
anatomy and physiology (1) 1
animals (1) 1
antibodies, monoclonal, murine-derived (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic antibiotics (1) 1
apoptosis (1) 1
astrocytoma (1) 1
autologous stem cell transplantation (1) 1
b-cell lymphoma (1) 1
beta (1) 1
biliary tract (1) 1
biliary tract cancer (1) 1
binding sites (1) 1
biochemistry (1) 1
biological activity (1) 1
bone-marrow-transplantation (1) 1
brain cancer (1) 1
brain research (1) 1
breast cancer (1) 1
btc (1) 1
cancer (1) 1
cancer methylation alteration (1) 1
cattle (1) 1
cell adhesion & migration (1) 1
cell culture (1) 1
cell death (1) 1
cell growth (1) 1
cell nucleus (1) 1
cell nucleus - metabolism (1) 1
cell physiology (1) 1
cellular stress responses (1) 1
cellular structures (1) 1
central nervous system diseases (1) 1
central nervous system neoplasms - drug therapy (1) 1
central nervous system neoplasms - mortality (1) 1
central nervous system neoplasms - radiotherapy (1) 1
central-nervous-system (1) 1
cerebrospinal-fluid (1) 1
chemotherapeutic approaches (1) 1
chemotherapeutic approaches; immunotherapy; lymphoma and hodgkin disease; hematology; oncology; cancer research (1) 1
chemotherapy (1) 1
chop (1) 1
chromosome 5 (1) 1
chronic lymphatic leukemia (1) 1
chronic lymphocytic leukemia (1) 1
clinical trials (1) 1
cll (1) 1
clustered pcdh (1) 1
colorectal adenoma (1) 1
colorectal carcinoma (1) 1
comprehensive assesment, diffuse large b cell lymphoma (1) 1
conformation (1) 1
consolidating radiotherapy (1) 1
cpg islands (1) 1
cra (1) 1
cranial irradiation - methods (1) 1
crc (1) 1
ctcf (1) 1
culture media - metabolism (1) 1
cytarabine (1) 1
cytarabine - adverse effects (1) 1
cytarabine - therapeutic use (1) 1
cytochemistry (1) 1
cytoplasm (1) 1
data analysis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 4, pp. 352 - 358
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 09/2009, Volume 94, Issue 9, pp. 1250 - 1258
Journal Article
CLINICAL EPIGENETICS, ISSN 1868-7075, 07/2019, Volume 11, Issue 1, p. 100
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.